Overview

Update
IPO / Stock
Went Public on Sep 30, 2015 / NASDAQ:MIRN
Total Equity Funding
$94.6M in 4 Rounds from 11 Investors
Headquarters:
Austin, TX
Description:
Mirna Therapeutics researches on and develops miRNA-directed human oncology therapies.
Founders:
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://www.mirnatherapeutics.com

Company Details

Update

Mirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on miRNA-directed human oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and an expansive IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.

Funding Rounds (6) - $109.9M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2015$16.8M / Private Equity0
Apr, 2015$41.8M / Series D11
Oct, 2012$34.5M / Series C5
Aug, 2011$1.5M / Series B0
Jun, 2010$10.3M / Grant0
Dec, 2009$5M / Grant0

Current Team (12)

Update

Offices/Locations (1)

Update
  • Office

    2150 Woodward St

    Suite 1000

    Austin, TX 78744

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos